Cargando…
A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
Higher-valent pneumococcal conjugate vaccines (PCVs) were licensed from 2009 in Europe; similar worldwide clinical effectiveness was observed for PCVs in routine use. Despite a proven medical need, PCV vaccination in Southern Europe remained suboptimal until 2015/16. We searched PubMed for manuscrip...
Autores principales: | Moreira, Marta, Castro, Olga, Palmieri, Melissa, Efklidou, Sofia, Castagna, Stefano, Hoet, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489303/ https://www.ncbi.nlm.nih.gov/pubmed/27996380 http://dx.doi.org/10.1080/21645515.2016.1263409 |
Ejemplares similares
-
Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001–2016
por: Alari, Anna, et al.
Publicado: (2019) -
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
por: Hausdorff, William P, et al.
Publicado: (2010) -
Further available immunization option to prevent pneumococcal disease
por: Vojtek, Ivo, et al.
Publicado: (2015) -
Value of pneumococcal PCR in respiratory samples for exclusion of pneumococcal pneumonia
por: Van Goethem, Sam, et al.
Publicado: (2023) -
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
por: Oligbu, Godwin, et al.
Publicado: (2019)